Aiolos Bio - Crunchbase Company Profile & Funding

Q: Who invested in Aiolos Bio?

Aiolos Bio has 5 investors including Forbion Capital Partners And Atlas Venture.

Q: When was the last funding round for Aiolos Bio?

Aiolos Bio closed its last funding round on obfuscated from a Series A round.

Q: How much funding has Aiolos Bio raised to date?

Aiolos Bio has raised obfuscated.

Overview

Aiolos Bio

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Aiolos Bio

CB Rank

29689

Aiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.

Acquired by

GlaxoSmithKline

Founded

obfuscation

Private

Series A

San Francisco, California, United States

11-50

www.aiolosbio.com

Biopharma

Biotechnology

Health Care

Funding Rounds

Series A

OBF

obfuscation

Key People

Khurem Farooq: CEO and Co-Founder
Ashley Taylor: Chief Technical Officer

Details

Legal Name

Aiolos Bio, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Khurem Farooq

About the Company

Long Description: Aiolos Bio is a biotech company focused on developing therapies for respiratory diseases like asthma as well as other immune conditions. The company is initially focused on advancing AIO-001, a monoclonal antibody therapy for moderate-to-severe asthma that only requires dosing every 6 months. Aiolos Bio was founded by an

accomplished team with decades of drug development experience and leadership in the biotech industry.

Predictions & Insights

Growth Insight

See this Growth Insight

Aiolos Bio is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

Vaccines

Aiolos Bio offers a broad portfolio of vaccines targeting infectious diseases like meningitis, shingles, RSV, flu, and polio, delivered globally.

Specialty Medicines

Focuses on treating diseases such as HIV, respiratory diseases, immune-mediated conditions like lupus, and cancer, with many being first or best-in-class.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Aiolos Bio	5	obfuscated obfuscation	Atlas Venture, Bain Capital Life Sciences, Forbion Capital Partners, Sofinnova Investments	Series A
obfuscated obfuscation	Series A - Aiolos Bio	5	obfuscated obfuscation	Atlas Venture, Bain Capital Life Sciences, Forbion Capital Partners, Sofinnova Investments	Series A
obfuscated obfuscation	Series A - Aiolos Bio	5	obfuscated obfuscation	Atlas Venture, Bain Capital Life Sciences, Forbion Capital Partners, Sofinnova Investments	Series A
obfuscated obfuscation	Series A - Aiolos Bio	5	obfuscated obfuscation	Atlas Venture, Bain Capital Life Sciences, Forbion Capital Partners, Sofinnova Investments	Series A
obfuscated obfuscation	Series A - Aiolos Bio	5	obfuscated obfuscation	Atlas Venture, Bain Capital Life Sciences, Forbion Capital Partners, Sofinnova Investments	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Aiolos Bio	5	obfuscated obfuscation	Atlas Venture, Bain Capital Life Sciences, Forbion Capital Partners, Sofinnova Investments	Series A
obfuscated obfuscation	Series A - Aiolos Bio	5	obfuscated obfuscation	Atlas Venture, Bain Capital Life Sciences, Forbion Capital Partners, Sofinnova Investments	Series A
obfuscated obfuscation	Series A - Aiolos Bio	5	obfuscated obfuscation	Atlas Venture, Bain Capital Life Sciences, Forbion Capital Partners, Sofinnova Investments	Series A
obfuscated obfuscation	Series A - Aiolos Bio	5	obfuscated obfuscation	Atlas Venture, Bain Capital Life Sciences, Forbion Capital Partners, Sofinnova Investments	Series A
obfuscated obfuscation	Series A - Aiolos Bio	5	obfuscated obfuscation	Atlas Venture, Bain Capital Life Sciences, Forbion Capital Partners, Sofinnova Investments	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Forbion Capital Partners	Yes	Series A - Aiolos Bio	—
Forbion Capital Partners	Yes	Series A - Aiolos Bio	—
Forbion Capital Partners	Yes	Series A - Aiolos Bio	—
Forbion Capital Partners	Yes	Series A - Aiolos Bio	—
Forbion Capital Partners	Yes	Series A - Aiolos Bio	—